Evogene Ltd. Logo

Evogene Ltd.

A computational biology company using AI to develop life-science products.

EVGN | TA

Overview

Corporate Details

ISIN(s):
IL0011050551
LEI:
Country:
Israel
Address:
13 Gad Feinstein St., Park Rehovot, 7638517 Rehovot

Description

Evogene Ltd. is a computational biology company that leverages artificial intelligence and big data to discover and develop novel life-science products. The company's proprietary Computational Predictive Biology (CPB) platform is designed to optimize the probability of success and reduce the time and cost of development. Evogene operates in the fields of human health, agriculture, and industrial applications. Its technology is organized into three AI-driven engines tailored for specific product types: MicroBoost AI for microbe-based products, ChemPass AI for small molecule-based products, and GeneRator AI for products based on genetic elements. The company's business model involves supporting subsidiary companies that focus on specific commercial fields, utilizing Evogene's technology to bring innovative products to market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2020-08-05 15:59
6K-Changes in Management
English 36.0 KB
2020-08-01 00:59
FORM F-3-REGISTRATION STATEMENT,SUBJECT TO COMPLETION, DATED JULY 31, 2020
English 248.9 KB
2020-08-01 00:59
FORM F-3-REGISTRATION STATEMENT,SUBJECT TO COMPLETION, DATED JULY 31, 2020
English 37.8 KB
2020-07-29 15:59
to Present at Jefferies Virtual 2020 Industrials Conference
English 145.4 KB
2020-07-29 15:59
to Present at Jefferies Virtual 2020 Industrials Conference
English 36.1 KB
2020-07-15 15:59
Evogene will release its financial results for the second quarter 2020 on Wedne…
English 712.4 KB
2020-07-15 15:59
Evogene will release its financial results for the second quarter 2020 on Wedne…
English 37.9 KB
2020-06-03 16:08
Evogene to Participate in CRISPR-IL Consortium to Provide end-to-end Artificial…
English 537.6 KB
2020-06-03 16:08
Evogene to Participate in CRISPR-IL Consortium to Provide end-to-end Artificial…
English 38.0 KB
2020-05-28 15:59
Changes in subsidiary management
English 127.5 KB
2020-05-28 15:59
Changes in subsidiary management
English 37.9 KB
2020-05-26 15:59
Evogene Reports First Quarter 2020 Financial Results
English 156.2 KB
2020-05-26 15:59
Evogene Reports First Quarter 2020 Financial Results
English 37.9 KB
2020-05-20 15:59
Evogene Launches its New Branding to Reflect the Company's Expanded Vision and…
English 5.8 MB
2020-05-20 15:59
Evogene Launches its New Branding to Reflect the Company's Expanded Vision and…
English 37.9 KB

Automate Your Workflow. Get a real-time feed of all Evogene Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Evogene Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Evogene Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.